4Q 2004), while revenue for 2005 was $2.7 bn (24% over $2.2 bn in 2004). R&D expenses were $138.186 M for 4Q 2005 ($107.428 M in 4Q 2004). For 2005, R&D expenses were $502.657 M ($391.802 M in 2004). Genzyme confirmed the revenue and earnings guidance for 2006 that it provided in Jan 2006.
Innovative enzymes put a new spin on detergents
- Publisher
- Elsevier Science
- Year
- 2005
- Weight
- 37 KB
- Volume
- 2005
- Category
- Article
- ISSN
- 1351-4180
No coin nor oath required. For personal study only.
โฆ Synopsis
NanoKinetix, has developed a nanocatalyst based on its proprietary NxCat technology, which significantly improves the upgrading of gasoline feedstock, commonly referred to as naphtha reforming. In side-by-side third-party laboratory comparisons with some of the industry's best reforming catalysts, the NxCat catalyst produced an increase in octane, which was the equivalent of going from regular-grade to premiumgrade gasoline. Additionally, a significant increase in hydrogen production was achieved. NxCat reforming catalysts are expected to enable refiners to improve their gasoline and petrochemical economics by more cost-effectively producing a premium-quality gasoline. Beyond the gasoline market, the NxCat reforming catalyst may also be used to produce more high-value petrochemical raw materials for the synthetic fibres and plastics industries.
๐ SIMILAR VOLUMES